Protalix BioTherapeutics Inc management update

Protalix BioTherapeutics Inc. (NYSE-M:PLX; Tel Aviv:PLX), Carmiel, Israel Business: Endocrine/Metabolic, Biosimilars, Biomanufacturing Retiring: David Aviezer as president and CEO, effective when his ...